Case ReportInternational Journal of Community Medicine and Public Health
Publication: An unusual case report of chlorpheniramine-induced severe thrombocytopenia
Int J Community Med Public Health. 2026;13(2):947-950.DOI10.18203/2394-6040.ijcmph20260321
Abstract
A rare but fatal illness is drug-induced thrombocytopenia (DITP). Severe thrombocytopenia is not frequently linked to antihistamines, especially first-generation H1 blockers like chlorpheniramine. We describe a rare instance of a 31-year-old man who used chlorpheniramine for rhinitis and thereafter got severe thrombocytopenia (platelet count=0×109/L). The patient had subcutaneous petechiae, bilateral conjunctival hemorrhage, and bleeding gums. Other causes were ruled out by laboratory tests, such as bone marrow analysis and peripheral blood smears. After receiving intravenous immunoglobulin (IVIG) and corticosteroids, the patient's platelet counts gradually recovered. This instance emphasizes how crucial it is to identify DITP as a side effect of chlorpheniramine so that early diagnosis and treatment may be carried out.
Keywords
Affiliations
- Department of Medicine, Hamad Medical Corporation, Doha, Qatar; College of Medicine, Qatar University, Doha, Qatar; Weill Cornell Medicine-Qatar, Doha, Qatar
- Pharmacy Department, Hamad Medical Corporation, Doha, Qatar
- Department of Medicine, Hamad Medical Corporation, Doha, Qatar
- College of Medicine, Syrian private university, Damascus, Syria
